|
Mar 29
|
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst
|
|
Mar 26
|
bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
|
|
Mar 25
|
bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call
|
|
Mar 18
|
Why Bluebird Bio Stock Flew Higher Than the Market Today
|
|
Mar 18
|
bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
|
|
Mar 13
|
Is Bluebird Bio Stock a Buy Now?
|
|
Mar 11
|
bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
|
|
Mar 5
|
Why Bluebird Bio Stock Dived Into the Red on Tuesday
|
|
Jan 27
|
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today
|
|
Jan 10
|
2 Red Flags for Bluebird Bio Stock
|
|
Jan 8
|
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook
|
|
Jan 4
|
Bluebird’s Plans to Win in Sickle Cell Come Into Focus
|
|
Jan 3
|
Better Risky Investment: Bluebird Bio vs. Shiba Inu
|
|
Jan 2
|
bluebird bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 24
|
If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today
|
|
Dec 23
|
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
|
|
Dec 22
|
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024
|
|
Dec 20
|
Bluebird Bio Stock Is in Free Fall Weeks After a Landmark FDA Approval. Here’s Why.
|
|
Dec 20
|
bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
|
|
Dec 18
|
bluebird bio, Inc. Announces Proposed Public Offering of Common Stock
|